Strategies for cell membrane functionalization

The ability to rationally manipulate and augment the cytoplasmic membrane can be used to overcome many of the challenges faced by conventional cellular therapies and provide innovative opportunities when combined with new biotechnologies. The focus of this review is on emerging strategies used in cell functionalization, highlighting both pioneering approaches and recent developments. These will be discussed within the context of future directions in this rapidly evolving field.

[1]  M. Tykocinski,et al.  Hierarchical Costimulator Thresholds for Distinct Immune Responses: Application of a Novel Two-Step Fc Fusion Protein Transfer Method1 , 2000, The Journal of Immunology.

[2]  C. Scaletta,et al.  Covalent cell surface functionalization of human fetal osteoblasts for tissue engineering. , 2011, Bioconjugate chemistry.

[3]  W. Yin,et al.  A novel therapeutic vaccine of GM-CSF/TNFalpha surface-modified RM-1 cells against the orthotopic prostatic cancer. , 2010, Vaccine.

[4]  Aoshuang Chen,et al.  Arming tumor-reactive T cells with costimulator B7-1 enhances therapeutic efficacy of the T cells. , 2006, Cancer research.

[5]  B. Foster,et al.  Modifying Dendritic Cells via Protein Transfer for Antitumor Therapeutics , 2007, Clinical Cancer Research.

[6]  J. Karp,et al.  Engineered mesenchymal stem cells with self-assembled vesicles for systemic cell targeting. , 2010, Biomaterials.

[7]  M. Goto,et al.  Protein lipidation catalyzed by microbial transglutaminase. , 2011, Chemistry.

[8]  D. Cojoc,et al.  Optical delivery of liposome encapsulated chemical stimuli to neuronal cells. , 2011, Journal of biomedical optics.

[9]  D. Legler,et al.  Differential insertion of GPI‐anchored GFPs into lipid rafts of live cells , 2005, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[10]  C. Scaletta,et al.  Functionalization of microstructured open-porous bioceramic scaffolds with human fetal bone cells. , 2012, Bioconjugate chemistry.

[11]  A. Nussinovitch,et al.  Hydrocolloid Coating of Xenopus laevis Embryos , 2000, Biotechnology progress.

[12]  H. Gröne,et al.  Generation of GPI-linked CCL5 based chemokine receptor antagonists for the suppression of acute vascular damage during allograft transplantation. , 2006, Protein engineering, design & selection : PEDS.

[13]  M. Pawlita,et al.  Biosynthetic Modulation of Sialic Acid-dependent Virus-Receptor Interactions of Two Primate Polyoma Viruses (*) , 1995, The Journal of Biological Chemistry.

[14]  N. Kampf.  The use of polymers for coating of cells , 2002 .

[15]  A. Hollander,et al.  Cell paintballing using optically targeted coacervate microdroplets , 2015, Chemical science.

[16]  Soong Ho Um,et al.  Surface functionalization of living cells with multilayer patches. , 2008, Nano letters.

[17]  D. Hatfield,et al.  Incorporation of modified amino acids into proteins in vivo. , 1984, Biochimica et biophysica acta.

[18]  Jos Malda,et al.  The roles of hypoxia in the in vitro engineering of tissues. , 2007, Tissue engineering.

[19]  J. Altin,et al.  Engrafting Costimulator Molecules onto Tumor Cell Surfaces with Chelator Lipids: A Potentially Convenient Approach in Cancer Vaccine Development1 , 2000, The Journal of Immunology.

[20]  T. Xia,et al.  Understanding biophysicochemical interactions at the nano-bio interface. , 2009, Nature materials.

[21]  Aoshuang Chen,et al.  Enhanced Antitumor Responses Elicited by Combinatorial Protein Transfer of Chemotactic and Costimulatory Molecules1 , 2007, The Journal of Immunology.

[22]  P. Burke,et al.  Metabolic engineering of monoclonal antibody carbohydrates for antibody-drug conjugation. , 2013, Bioconjugate chemistry.

[23]  M. Tykocinski,et al.  Protein transfer of glycosyl-phosphatidylinositol (GPI)-modified murine B7-1 and B7-2 costimulators. , 1999, Journal of immunotherapy.

[24]  L. Goldstein,et al.  Use of cationized ferritin as a label of negative charges on cell surfaces. , 1972, Journal of ultrastructure research.

[25]  Narendra P. Singh,et al.  ProtEx™: A Novel Technology to Display Exogenous Proteins on the Cell Surface for Immunomodulation , 2005, Annals of the New York Academy of Sciences.

[26]  J. Kyte.  Molecular considerations relevant to the mechanism of active transport , 1981, Nature.

[27]  H. Ploegh,et al.  Lipid modification of proteins through sortase-catalyzed transpeptidation. , 2008, Journal of the American Chemical Society.

[28]  E. Gorter,et al.  ON BIMOLECULAR LAYERS OF LIPOIDS ON THE CHROMOCYTES OF THE BLOOD , 1925, The Journal of experimental medicine.

[29]  L. Rajendran,et al.  Lipid rafts and membrane dynamics , 2005, Journal of Cell Science.

[30]  Brian Derby,et al.  Printing and Prototyping of Tissues and Scaffolds , 2012, Science.

[31]  Jennifer A. Prescher,et al.  Rapid detection, discovery, and identification of post‐translationally myristoylated proteins during apoptosis using a bio‐orthogonal azidomyristate analog , 2008, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[32]  S. Mann,et al.  A polymer surfactant corona dynamically replaces water in solvent-free protein liquids and ensures macromolecular flexibility and activity. , 2012, Journal of the American Chemical Society.

[33]  I. Ko,et al.  Targeting improves MSC treatment of inflammatory bowel disease. , 2010, Molecular therapy : the journal of the American Society of Gene Therapy.

[34]  A. Nussinovitch,et al.  Alginate Coating of Xenopus laevis Embryos , 2000, Biotechnology progress.

[35]  F. Tamanoi,et al.  A tagging-via-substrate technology for detection and proteomics of farnesylated proteins. , 2004, Proceedings of the National Academy of Sciences of the United States of America.

[36]  Yechezkel Barenholz,et al.  Liposome application: problems and prospects , 2001 .

[37]  Narendra P. Singh,et al.  Cell membrane modification for rapid display of proteins as a novel means of immunomodulation: FasL-decorated cells prevent islet graft rejection. , 2002, Immunity.

[38]  A. Perriman,et al.  Ultra-fast stem cell labelling using cationised magnetoferritin. , 2016, Nanoscale.

[39]  Teng Ma,et al.  Facile functionalization and assembly of live cells with microcontact-printed polymeric biomaterials. , 2015, Acta biomaterialia.

[40]  R. Edwards,et al.  Early Stages of Fertilization in vitro of Human Oocytes Matured in vitro , 1969, Nature.

[41]  Y. Iwasaki,et al.  Preparation of biointeractive glycoprotein-conjugated hydrogels through metabolic oligosacchalide engineering. , 2014, Bioconjugate chemistry.

[42]  Teruyuki Nagamune,et al.  Protein cell-surface display through in situ enzymatic modification of proteins with a poly(Ethylene glycol)-lipid. , 2013, Biotechnology and bioengineering.

[43]  D. Irvine,et al.  Freely Suspended Cellular “Backpacks” Lead to Cell Aggregate Self-Assembly , 2010, Biomacromolecules.

[44]  W. Reutter,et al.  Biosynthesis of a nonphysiological sialic acid in different rat organs, using N-propanoyl-D-hexosamines as precursors. , 1992, The Journal of biological chemistry.

[45]  Michael Edidin,et al.  Lipids on the frontier: a century of cell-membrane bilayers , 2003, Nature Reviews Molecular Cell Biology.

[46]  J. George.  Stem cell therapy in acute myocardial infarction: a review of clinical trials. , 2010, Translational research : the journal of laboratory and clinical medicine.

[47]  V. Goldberg,et al.  Targeted delivery of progenitor cells for cartilage repair , 2004, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[48]  S. Neelamegham,et al.  The use of surface immobilization of P-selectin glycoprotein ligand-1 on mesenchymal stem cells to facilitate selectin mediated cell tethering and rolling. , 2013, Biomaterials.

[49]  Craig T. Armstrong,et al.  Artificial membrane-binding proteins stimulate oxygenation of stem cells during engineering of large cartilage tissue , 2015, Nature Communications.

[50]  David R. Liu,et al.  Mammalian cell penetration, siRNA transfection, and DNA transfection by supercharged proteins , 2009, Proceedings of the National Academy of Sciences.

[51]  Charles P. Lin,et al.  Ex vivo glycan engineering of CD44 programs human multipotent mesenchymal stromal cell trafficking to bone , 2008, Nature Medicine.

[52]  Molly M. Stevens,et al.  Exploring and exploiting chemistry at the cell surface. , 2011, Nature chemistry.

[53]  Soong Ho Um,et al.  Therapeutic cell engineering using surface-conjugated synthetic nanoparticles , 2010, Nature Medicine.

[54]  Samir Mitragotri,et al.  Cell‐Based Drug Delivery Devices Using Phagocytosis‐Resistant Backpacks , 2011, Advanced materials.

[55]  David R. Liu,et al.  Supercharging proteins can impart unusual resilience. , 2007, Journal of the American Chemical Society.

[56]  M. Tykocinski,et al.  Glycosyl-Phosphatidylinositol Reanchoring Unmasks Distinct Antigen-Presenting Pathways for CD1b and CD1c1 , 2000, The Journal of Immunology.

[57]  C. Bertozzi,et al.  Cell surface engineering by a modified Staudinger reaction. , 2000, Science.

[58]  J. Kao,et al.  Nonpolar substitution at the C-terminus of the prion protein, a mimic of the glycosylphosphatidylinositol anchor, partially impairs amyloid fibril formation. , 2007, Biochemistry.

[59]  Rachelle N. Palchesko,et al.  Shrink Wrapping Cells in a Defined Extracellular Matrix to Modulate the Chemo-Mechanical Microenvironment , 2014, Cellular and molecular bioengineering.

[60]  L. Xia,et al.  Surface fucosylation of human cord blood cells augments binding to P-selectin and E-selectin and enhances engraftment in bone marrow. , 2004, Blood.

[61]  N. Stephanopoulos,et al.  Choosing an effective protein bioconjugation strategy. , 2011, Nature chemical biology.

[62]  K. Ribbeck,et al.  Sugar-mediated disassembly of mucin/lectin multilayers and their use as pH-Tolerant, on-demand sacrificial layers. , 2014, Biomacromolecules.

[63]  I. Ko,et al.  Targeting mesenchymal stem cells to activated endothelial cells. , 2009, Biomaterials.

[64]  R. Kornowski,et al.  Stem Cell Therapy in Perspective , 2003, Circulation.

[65]  Zhiliang Wang,et al.  Display of Fas Ligand Protein on Cardiac Vasculature as a Novel Means of Regulating Allograft Rejection , 2003, Circulation.

[66]  P. Nelson,et al.  GPI-anchored TIMP-1 treatment renders renal cell carcinoma sensitive to FAS-meditated killing , 2006, Oncogene.

[67]  P. Greenberg.  Adoptive T cell therapy of tumors: mechanisms operative in the recognition and elimination of tumor cells. , 1991, Advances in immunology.

[68]  K. Sell,et al.  Protein transfer of glycosyl-phosphatidylinositol-B7-1 into tumor cell membranes: a novel approach to tumor immunotherapy. , 1999, Cancer research.

[69]  Jennifer A. Prescher,et al.  Finding the right (bioorthogonal) chemistry. , 2014, ACS chemical biology.

[70]  Yan Li,et al.  Asymmetric biodegradable microdevices for cell-borne drug delivery. , 2015, ACS applied materials & interfaces.

[71]  B. Peterson.  Synthetic mimics of mammalian cell surface receptors: prosthetic molecules that augment living cells. , 2005, Organic & biomolecular chemistry.

[72]  M. Tykocinski,et al.  Glycosylphosphatidylinositol-modified murine B7-1 and B7-2 retain costimulator function. , 1995, Journal of immunology.

[73]  David R. Liu,et al.  Cellular uptake mechanisms and endosomal trafficking of supercharged proteins. , 2012, Chemistry & biology.

[74]  Carolyn R Bertozzi,et al.  Incorporation of azides into recombinant proteins for chemoselective modification by the Staudinger ligation , 2001, Proceedings of the National Academy of Sciences of the United States of America.

[75]  Teruyuki Nagamune,et al.  Rapid Protein Anchoring into the Membranes of Mammalian Cells Using Oleyl Chain and Poly(ethylene glycol) Derivatives , 2004, Biotechnology progress.

[76]  T. Pan,et al.  Induction of antitumor immunity via intratumoral tetra-costimulator protein transfer. , 2001, Cancer research.

[77]  Dan Cojoc,et al.  Use of optical tweezers technology for long-term, focal stimulation of specific subcellular neuronal compartments. , 2011, Integrative biology : quantitative biosciences from nano to macro.

[78]  M. Davis,et al.  Expression of T cell antigen receptor heterodimers in a lipid-linked form. , 1990, Science.

[79]  B. Kholodenko.  Cell-signalling dynamics in time and space , 2006, Nature Reviews Molecular Cell Biology.

[80]  Carolyn R Bertozzi,et al.  Bioorthogonal chemistry: fishing for selectivity in a sea of functionality. , 2009, Angewandte Chemie.

[81]  Jeffrey M Karp,et al.  Chemical engineering of mesenchymal stem cells to induce a cell rolling response. , 2008, Bioconjugate chemistry.

[82]  D. Ingber,et al.  Reconstituting Organ-Level Lung Functions on a Chip , 2010, Science.

[83]  Michael Loran Dustin,et al.  The Lymphocyte Function–associated Antigen 1 I Domain Is a Transient Binding Module for Intercellular Adhesion Molecule (ICAM)-1 and ICAM-3 in Hydrodynamic Flow , 1997, The Journal of experimental medicine.

[84]  Douglas D. Taylor,et al.  Primary tumor cells resected from cancer patients and decorated with a novel form of CD80 protein serve as effective antigen-presenting cells for the induction of autologous T cell immune responses ex vivo. , 2006, Human gene therapy.

[85]  S. A. Kim,et al.  The use of palmitate-conjugated protein A for coating cells with artificial receptors which facilitate intercellular interactions. , 1993, Journal of immunological methods.

[86]  R. Sessions,et al.  Molecular dynamics simulations reveal a dielectric-responsive coronal structure in protein-polymer surfactant hybrid nanoconstructs. , 2014, Journal of the American Chemical Society.

[87]  Udayanath Aich,et al.  Designing a binding interface for control of cancer cell adhesion via 3D topography and metabolic oligosaccharide engineering. , 2011, Biomaterials.

[88]  P. Selvaraj,et al.  Designer cancer vaccines made easy: protein transfer of immunostimulatory molecules for use in therapeutic tumor vaccines. , 2001, Frontiers in bioscience : a journal and virtual library.

[89]  Ryousuke Kamiura.  [Engineering chemical reactivity on cell surfaces through oligosaccharide biosynthesis]. , 2007, Tanpakushitsu kakusan koso. Protein, nucleic acid, enzyme.

[90]  Teruyuki Nagamune,et al.  Poly(ethylene glycol)-Lipid-Conjugated Antibodies Enhance Dendritic Cell Phagocytosis of Apoptotic Cancer Cells , 2012, Pharmaceuticals.

[91]  S. Singer,et al.  The fluid mosaic model of the structure of cell membranes. , 1972, Science.

[92]  Stephen Mann,et al.  Reversible dioxygen binding in solvent-free liquid myoglobin. , 2010, Nature chemistry.

[93]  Jennifer A. Prescher,et al.  Chemistry in living systems , 2005, Nature chemical biology.

[94]  Sharon H Chou,et al.  Palmitate-derivatized human IL-2: a potential anticancer immunotherapeutic of low systemic toxicity , 2013, Cancer Immunology, Immunotherapy.

[95]  P. Selvaraj,et al.  Glycolipid-anchored IL-12 expressed on tumor cell surface induces antitumor immune response. , 2002, Cancer research.

[96]  S. Mitragotri,et al.  Monocyte-mediated delivery of polymeric backpacks to inflamed tissues: a generalized strategy to deliver drugs to treat inflammation. , 2015, Journal of controlled release : official journal of the Controlled Release Society.

[97]  M. Penn,et al.  Development of a peptide-targeted, myocardial ischemia-homing, mesenchymal stem cell , 2012, Journal of drug targeting.

[98]  M. Gray,et al.  Effect of temperature on hybridoma cell cycle and MAb production , 1992, Biotechnology and bioengineering.

[99]  David R. Liu,et al.  Potent Delivery of Functional Proteins into Mammalian Cells in Vitro and in Vivo Using a Supercharged Protein , 2010, ACS chemical biology.

[100]  S. Kesari,et al.  Distearoyl Anchor‐Painted Erythrocytes with Prolonged Ligand Retention and Circulation Properties In Vivo , 2014, Advanced healthcare materials.

[101]  F. Gage,et al.  The glycans of stem cells. , 2007, Current opinion in chemical biology.

[102]  P. Selvaraj,et al.  Development of therapeutic vaccines by direct modification of cell membranes from surgically removed human tumor tissue with immunostimulatory molecules. , 2001, Vaccine.

[103]  K. Okawa,et al.  Plasmacytoid dendritic cells: from specific surface markers to specific cellular functions. , 2002, Human immunology.

[104]  C. Bertozzi,et al.  Engineered cell surfaces: fertile ground for molecular landscaping. , 1997, Chemistry & biology.

[105]  Yingming Zhao,et al.  Tagging-via-substrate strategy for probing O-GlcNAc modified proteins. , 2005, Journal of proteome research.

[106]  Carolyn R. Bertozzi,et al.  Noncovalent cell surface engineering: incorporation of bioactive synthetic glycopolymers into cellular membranes. , 2008, Journal of the American Chemical Society.

[107]  R Langer,et al.  Tissue engineering by cell transplantation using degradable polymer substrates. , 1991, Journal of biomechanical engineering.

[108]  D. Goeddel,et al.  The TNF receptor 1-associated protein TRADD signals cell death and NF-κB activation , 1995, Cell.

[109]  K. Sell,et al.  Construction, purification, and functional incorporation on tumor cells of glycolipid-anchored human B7-1 (CD80). , 1995, Proceedings of the National Academy of Sciences of the United States of America.

[110]  In‐San Kim,et al.  Enhanced delivery of T cells to tumor after chemotherapy using membrane-anchored, apoptosis-targeted peptide. , 2012, Journal of controlled release : official journal of the Controlled Release Society.

[111]  D. Metzinger,et al.  A novel approach to cancer immunotherapy: tumor cells decorated with CD80 generate effective antitumor immunity. , 2003, Cancer research.